Trial Details
COMPLETEDBasic Information
| Clinical ID | c139 |
|---|---|
| Identifier | NCT02407236 |
| Trial Title | A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative|Inflammatory Bowel Diseases |
| Interventions | DRUG: Placebo IV|DRUG: Placebo SC|DRUG: Ustekinumab IV|DRUG: Ustekinumab SC |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2015-07-10 |
|---|---|
| Primary Completion Date | 2018-08-10 |
| Completion Date | 2021-11-30 |